MaxQ AI is a leading healthcare startup specializing in artificial intelligence solutions. Founded in 2013, the company is headquartered in Israel with a presence in Andover, MA. MaxQ AI's mission is to revolutionize healthcare by equipping physicians with the tools to deliver smarter care through enhanced clinical workflows. The company's innovative software leverages AI to interpret medical images and patient data, ultimately assisting in improved patient triage and providing valuable clinical insights. MaxQ AI has received significant support, with a notable $7.00M Series A investment made on 01 December 2017, signaling confidence in the company's potential to disrupt the health care industry. With a focus on diagnosing critical conditions such as intracranial hemorrhage, stroke, and brain trauma, MaxQ AI's technology enables physicians to make faster and more accurate decisions. Collaborating with esteemed clinical and industry partners, MaxQ AI is well-positioned to drive significant advancements in healthcare.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series A - MaxQ | $7.00M | - | 01 Dec 2017 | |
Seed Round - MaxQ | $2.00M | - | 02 Mar 2016 | |
Seed Round - MaxQ | Unknown | - | 01 Apr 2015 |
No recent news or press coverage available for MaxQ-AI.